MedTrace Logo

Gestational Diabetes Mellitus Trial (GDM)

NCT00069576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7381

Last updated 2019-07-15

Study results available
· View outcomes & findings →

Summary

Gestational diabetes mellitus (GDM) is a type of diabetes (high blood sugar) that occurs in pregnant women. This study will determine whether treating pregnant women who have mild GDM improves the health of their babies. The follow-up study will examine whether factors during the previous pregnancy (such as blood sugar during pregnancy) are associated with the woman and her child's health 4-9 years later.

Conditions

  • Diabetes, Gestational

Interventions

BEHAVIORAL

nutritional counseling

BEHAVIORAL

self blood glucose monitoring

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • The George Washington University Biostatistics Center

    lead OTHER

Principal Investigators

  • Mark B. Landon, MD · Ohio State University

  • Uma Reddy, MD, MPH · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

  • Elizabeth A Thom, Ph.D. · George Washington University Biostatistics Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-10-31
Primary Completion
2007-11-30
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00069576 on ClinicalTrials.gov